Advertisement

Topics

Multiple Sclerosis Drugs and Therapeutic Pipeline Review H1 2017 Research Available at RnR ...

13:00 EDT 4 Jul 2017 | BioMedReports - Blog

The Multiple Sclerosis  Pipeline Review H1 2017provides comprehensive information on the therapeutics under development for Multiple Sclerosis (Central Nervous System), complete with analysis

Read more...

Original Article: Multiple Sclerosis Drugs and Therapeutic Pipeline Review H1 2017 Research Available at RnR ...

NEXT ARTICLE

More From BioPortfolio on "Multiple Sclerosis Drugs and Therapeutic Pipeline Review H1 2017 Research Available at RnR ..."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Multiple Sclerosis MS
Multiple sclerosis (MS) is the most common disabling neurological condition affecting 100,000 young adults in the UK. The condition results from autoimmune damage to myelin, causing interference in nerve signaling. Symptoms experienced depend on the pa...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...